These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure. Butler J; Emerman C; Peacock WF; Mathur VS; Young JB; Nephrol Dial Transplant; 2004 Feb; 19(2):391-9. PubMed ID: 14736964 [TBL] [Abstract][Full Text] [Related]
5. Effect of nesiritide infusion duration on renal function in acutely decompensated heart failure patients. Chow SL; Peng JT; Okamoto MP; Heywood JT Ann Pharmacother; 2007 Apr; 41(4):556-61. PubMed ID: 17389662 [TBL] [Abstract][Full Text] [Related]
6. The dose-dependent effect of nesiritide on renal function in patients with acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trials. Xiong B; Wang C; Yao Y; Huang Y; Tan J; Cao Y; Zou Y; Huang J PLoS One; 2015; 10(6):e0131326. PubMed ID: 26107522 [TBL] [Abstract][Full Text] [Related]
7. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695 [TBL] [Abstract][Full Text] [Related]
8. Effect of nesiritide on renal function in patients admitted for decompensated heart failure. Arora S; Clarke K; Srinivasan V; Gradman A QJM; 2007 Nov; 100(11):699-706. PubMed ID: 17971392 [TBL] [Abstract][Full Text] [Related]
9. Comparative effects of nesiritide and nitroglycerin on renal function, and incidence of renal injury by traditional and RIFLE criteria in acute heart failure. Ng TM; Ackerbauer KA; Hyderi AF; Hshieh S; Elkayam U J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):79-85. PubMed ID: 21536855 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial. Yancy CW; Krum H; Massie BM; Silver MA; Stevenson LW; Cheng M; Kim SS; Evans R; Circ Heart Fail; 2008 May; 1(1):9-16. PubMed ID: 19808265 [TBL] [Abstract][Full Text] [Related]
11. Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery. Ejaz AA; Martin TD; Johnson RJ; Winterstein AG; Klodell CT; Hess PJ; Ali AK; Whidden EM; Staples NL; Alexander JA; House-Fancher MA; Beaver TM J Thorac Cardiovasc Surg; 2009 Oct; 138(4):959-64. PubMed ID: 19660420 [TBL] [Abstract][Full Text] [Related]
13. Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure). Wan SH; Stevens SR; Borlaug BA; Anstrom KJ; Deswal A; Felker GM; Givertz MM; Bart BA; Tang WH; Redfield MM; Chen HH Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27512103 [TBL] [Abstract][Full Text] [Related]
14. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide. Kurien S; Warfield KT; Wood CM; Miller WL Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223 [TBL] [Abstract][Full Text] [Related]
15. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group. Mills RM; LeJemtel TH; Horton DP; Liang C; Lang R; Silver MA; Lui C; Chatterjee K J Am Coll Cardiol; 1999 Jul; 34(1):155-62. PubMed ID: 10400005 [TBL] [Abstract][Full Text] [Related]
16. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF) JAMA; 2002 Mar; 287(12):1531-40. PubMed ID: 11911755 [TBL] [Abstract][Full Text] [Related]
17. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. Colucci WS; Elkayam U; Horton DP; Abraham WT; Bourge RC; Johnson AD; Wagoner LE; Givertz MM; Liang CS; Neibaur M; Haught WH; LeJemtel TH N Engl J Med; 2000 Jul; 343(4):246-53. PubMed ID: 10911006 [TBL] [Abstract][Full Text] [Related]
18. Nesiritide added to standard care favorably reduces systolic blood pressure compared with standard care alone in patients with acute decompensated heart failure. Peacock WF; Emerman CL; Silver MA Am J Emerg Med; 2005 May; 23(3):327-31. PubMed ID: 15915407 [TBL] [Abstract][Full Text] [Related]
19. Impact of empiric nesiritide or milrinone infusion on early postoperative recovery after Fontan surgery: a randomized, double-blind, placebo-controlled trial. Costello JM; Dunbar-Masterson C; Allan CK; Gauvreau K; Newburger JW; McGowan FX; Wessel DL; Mayer JE; Salvin JW; Dionne RE; Laussen PC Circ Heart Fail; 2014 Jul; 7(4):596-604. PubMed ID: 24906491 [TBL] [Abstract][Full Text] [Related]
20. Treatment with B-type natriuretic peptide for chronic decompensated heart failure: insights learned from the follow-up serial infusion of nesiritide (FUSION) trial. Yancy CW Heart Fail Rev; 2004 Jul; 9(3):209-16. PubMed ID: 15809819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]